Acute myeloid leukemia can be injected with thymopentapeptide.
Thymopentapeptide is a small molecule protein, this drug has the function of regulating immunity, after intramuscular injection of acute myeloid leukemia patients, it can improve the immune function of the patient’s body to a certain extent, so that the situation of decreased immunity has been significantly improved.
After the onset of acute myeloid leukemia, the hematopoietic function of the bone marrow of the patient may be seriously damaged, which leads to a decline in the number of white blood cells, and after radiotherapy, the body’s immunity will be further reduced, so you can follow the doctor’s instructions to inject thymopentapeptide, and at the same time, we should also strengthen the appropriate nutrition and proper rest, in order to make the condition stable and improve.
If nausea, fever, fatigue and other discomforts occur after the injection of thymopentin, if the patient can not tolerate it or the symptoms continue to worsen, it is necessary to stop the medication in time for observation, and it is best to consult a doctor for examination and treatment. This drug is contraindicated for patients with allergic reactions and those who need immunosuppression at the initial stage of organ transplantation.
Specific diagnosis and treatment should be carried out under the guidance of physicians.